Tokyo, Japan—The Tosoh Corporation–developed 2.5D (two and half dimensional) Cell Culture System will facilitate drug discovery and regenerative medicine by simplifying the culturing of large quantities of uniformly sized cell masses. The system enables the spontaneous formation of many uniform cell masses on an adhesion area. Tosoh plans to introduce its 2.5D Cell Culture System […]

SEATTLE–TwinStrand Biosciences, Inc. (TwinStrand), the pioneer in Duplex Sequencing technology, which delivers clearer insights to researchers and clinicians in applications ranging from residual cancer detection to genetic toxicology, today announced that the company has implemented a reorganization designed to sustain growth through a focus on key commercial initiatives. As part of this effort, TwinStrand has […]

100,000 square foot facility to support company plans for growth in clinical laboratory services, drug development services and product innovations Launch event to feature updates on Enzo plans for business growth and perspectives on prospects for the Long Island business community from community leaders including Senator John Brooks and Assemblyman Steve Stern New York, NY […]

Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies 46 scientific experts based in Cologne, Germany, join the Cytiva team in the genomic medicine space Cytiva customers will have immediate access to technologies that solve some of the greatest challenges in bringing gene therapies to patients Global life […]

High-throughput, multi-omic single-cell Tapestri® VCN Assay quantifies vector copy number (VCN) and transduction in individual engineered cells in a single assay — saving precious time and sample while working to ensure safety and potentially reducing the risk of clinical holds. Increasingly stringent U.S. Food and Drug Administration (FDA) guidelines highlight the need to quantify VCN […]

The microfluidics-based system accommodates scalable throughputs to address specific and evolving project needsSOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the launch of the X9™ Real-Time PCR System, an innovative high-capacity genomics instrument offering superior efficiency. X9 enables […]

Enhanced NGS portfolio includes Interpret Software updates and enables rapid and confident variant detection even in difficult-to-sequence regions  Oxford, UK –  OGT, A Sysmex Group Company, announces the recent launch of several new solutions to support its growing NGS portfolio. These include the SureSeq™ Myeloid Plus panel, which has been designed to detect aberrations in genes […]

Novel RNA Seq-based technology offers unbiased profiling of all seven human TCR and BCR variable regions from a single sample MOUNTAIN VIEW, CA—Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T-cell receptor […]

New BioXp® Error Corrected Libraries have two-fold increase in sequence fidelity SAN DIEGO — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release of BioXp® Error-corrected Libraries kits that enable researchers to automate synthesis of DNA variant libraries on the award-winning BioXp® automated synthetic biology workstation. “This addition to […]

MENLO PARK, Calif.–Oct. 4, 2022–Personalis, Inc. (Nasdaq: PSNL) has joined with Duke University and Olink Proteomics AB to form a research collaboration to study the effects of immunotherapy on advanced gastroesophageal cancer. Specifically, the collaboration will focus on identifying composite biomarkers—those that integrate multiple biological entities into a single readout—to help guide therapeutic decision making. […]